Vivos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised
Vivos Therapeutics, Inc. (VVOS) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised of 1.98 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised · last filed 2026-08-14
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2026-06-30 was 0.00 shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2026-03-31 was 1.98M shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for the quarter ending 2024-12-31 was 345.00K shares.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2025 was 180.00K shares, a 89.65% decline from fiscal 2024.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2024 was 1.74M shares, a 178.69% increase from fiscal 2023.
- Vivos Therapeutics, Inc. share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised for fiscal 2023 was 624.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | 1.98M shares 10-Q · filed 2026-08-14 | 1.98M shares derived: sum of 3 quarters · filed 2026-08-14 | |
| 2026-03-31 | 1.98M shares 10-Q · filed 2026-05-20 | 1.98M shares derived: sum of 2 quarters · filed 2026-05-20 | ||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 180.00K shares 10-K · filed 2026-04-15 | ||
| 2025-09-30 | 180.00K shares 10-Q · filed 2025-11-19 | |||
| 2024-12-31 | 345.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | 345.00K shares derived: sum of 2 quarters · filed 2026-04-15 | 345.00K shares derived: sum of 3 quarters · filed 2026-04-15 | 1.74M shares 10-K · filed 2026-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 1.39M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 1.39M shares 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | 1.39M shares 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | 624.00K shares 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |